Literature DB >> 18688573

Expression of functional recombinant human factor IX in milk of mice.

Sharon F C Lisauskas1, Nicolau B Cunha, Giovanni R Vianna, Erica A Mendes, Gustavo L Ramos, Andréia Q Maranhão, Marcelo M Brígido, Jussara O S C Almeida, Heloisa A Baptista, Fabiana L T Motta, João B Pesquero, Francisco J L Aragão, Elíbio L Rech.   

Abstract

Human factor IX is synthesized in the liver and secreted in the blood, where it participates in a group of reactions involving coagulation factors and proteins that permit sanguinary coagulation. In this work two lines of transgenic mice were developed to express the FIX gene in the mammalian glands under control of milk beta-casein promoter. The founding females secreted the FIX in their milk (3% total soluble protein). The stable integration of transgene was confirmed by southern blot analysis. The presence of the FIX recombinant protein in the milk of transgenic females was confirmed by western blot and the clotting activity was revealed in blood-clotting assays. The coagulation activity in human blood treated with recombinant FIX increased while the time of coagulation decreased. Our results confirm the production of a large amount of recombinant biologically active FIX in the mammary gland of transgenic mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688573     DOI: 10.1007/s10529-008-9818-y

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  5 in total

Review 1.  Genome editing revolutionize the creation of genetically modified pigs for modeling human diseases.

Authors:  Jing Yao; Jiaojiao Huang; Jianguo Zhao
Journal:  Hum Genet       Date:  2016-07-18       Impact factor: 4.132

2.  Development of a Multiplex PCR Test System for the Determination of a Transgene Based on the pBC1 Plasmid and Its Derivatives for the Expression of Recombinant Proteins in Mus musculus Milk.

Authors:  V A Kalmykov; P A Kusov; A V Deykin
Journal:  Dokl Biochem Biophys       Date:  2019-06-14       Impact factor: 0.788

3.  Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds.

Authors:  Nicolau B Cunha; André M Murad; Gustavo L Ramos; Andréia Q Maranhão; Marcelo M Brígido; Ana Cláudia G Araújo; Cristiano Lacorte; Francisco J L Aragão; Dimas T Covas; Aparecida M Fontes; Gustavo H M F Souza; Giovanni R Vianna; Elíbio L Rech
Journal:  Transgenic Res       Date:  2010-11-11       Impact factor: 2.788

4.  Evaluation of the α-casein (CSN1S1) locus as a potential target for a site-specific transgene integration.

Authors:  A V Smirnov; G V Kontsevaya; T A Shnaider; A M Yunusova; N A Feofanova; L A Gerlinskaya; I A Serova; O L Serov; N R Battulin
Journal:  Sci Rep       Date:  2022-05-14       Impact factor: 4.996

5.  Engineering protein processing of the mammary gland to produce abundant hemophilia B therapy in milk.

Authors:  Jianguo Zhao; Weijie Xu; Jason W Ross; Eric M Walters; Stephen P Butler; Jeff J Whyte; Lindsey Kelso; Mostafa Fatemi; Nicholas C Vanderslice; Keith Giroux; Lee D Spate; Melissa S Samuel; Cliff N Murphy; Kevin D Wells; Nick C Masiello; Randall S Prather; William H Velander
Journal:  Sci Rep       Date:  2015-09-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.